Edges in Network
| Network | GSE14208_top500tf - GSE14208 - SiGN-BN HC+Bootstrap |
| Network Description | Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy |
| Node | NFE2L3 |
| Upstream (Parents) |
|---|
| (<<) GATA4 → NFE2L3 |
| (<<) MYC → NFE2L3 |
| (<<) TEAD4 → NFE2L3 |
| (<<) E2F5 → NFE2L3 |
| (<<) E2F3 → NFE2L3 |
| (<<) NOLC1 → NFE2L3 |
| (<<) CREM → NFE2L3 |
| (<<) TSC22D3 → NFE2L3 |
| (<<) GABPB1 → NFE2L3 |
| (<<) HSF2 → NFE2L3 |
| (<<) ADNP → NFE2L3 |
| (<<) E2F6 → NFE2L3 |
| (<<) ESRRA → NFE2L3 |
| Downstream (Children) |
|---|
| NFE2L3 → HMGA2 (>>) |
| NFE2L3 → SCML1 (>>) |
| NFE2L3 → ARNTL2 (>>) |
| NFE2L3 → ZNF165 (>>) |
| NFE2L3 → HOXA1 (>>) |
| NFE2L3 → MAF (>>) |
| NFE2L3 → MAFF (>>) |
| NFE2L3 → TGIF1 (>>) |
| NFE2L3 → CSDA (>>) |
| NFE2L3 → ZNF45 (>>) |
| NFE2L3 → GTF2H4 (>>) |
| NFE2L3 → NFATC3 (>>) |
| NFE2L3 → BUD31 (>>) |
